Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Personality and congenital adrenal hyperplasia: possible effects of prenatal androgen exposure.

Mathews GA, Fane BA, Conway GS, Brook CG, Hines M.

Horm Behav. 2009 Feb;55(2):285-91. doi: 10.1016/j.yhbeh.2008.11.007. Epub 2008 Nov 28.

2.

Motor development in individuals with congenital adrenal hyperplasia: strength, targeting, and fine motor skill.

Collaer ML, Brook CG, Conway GS, Hindmarsh PC, Hines M.

Psychoneuroendocrinology. 2009 Feb;34(2):249-58. doi: 10.1016/j.psyneuen.2008.09.007. Epub 2008 Oct 19.

3.

A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature.

Elder CJ, Barton JS, Brook CG, Preece MA, Dattani MT, Hindmarsh PC.

Horm Res. 2008;70(2):89-92. doi: 10.1159/000139150. Epub 2008 Jun 12.

PMID:
18547955
4.

A randomised study of two doses of biosynthetic human growth hormone on final height of pubertal children with growth hormone deficiency.

Coelho R, Brook CG, Preece MA, Stanhope RG, Dattani MT, Hindmarsh PC.

Horm Res. 2008;70(2):85-8. doi: 10.1159/000139149. Epub 2008 Jun 12.

PMID:
18547954
5.
6.

Androgens and autistic traits: A study of individuals with congenital adrenal hyperplasia.

Knickmeyer R, Baron-Cohen S, Fane BA, Wheelwright S, Mathews GA, Conway GS, Brook CG, Hines M.

Horm Behav. 2006 Jun;50(1):148-53. Epub 2006 Apr 19.

PMID:
16624315
7.

Classic congenital adrenal hyperplasia and puberty.

Charmandari E, Brook CG, Hindmarsh PC.

Eur J Endocrinol. 2004 Nov;151 Suppl 3:U77-82. Review.

PMID:
15554890
8.

Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency.

Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.

J Pediatr Endocrinol Metab. 2003 Oct-Nov;16(8):1119-30.

PMID:
14594172
9.

Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.

Spoudeas HA, Charmandari E, Brook CG.

Med Pediatr Oncol. 2003 Apr;40(4):224-9.

PMID:
12555249
10.

Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia.

Charmandari E, Johnston A, Honour JW, Brook CG, Hindmarsh PC.

J Pediatr Endocrinol Metab. 2002 Apr;15(4):435-9.

PMID:
12008691
11.

Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.

Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.

J Clin Endocrinol Metab. 2002 May;87(5):2238-44.

PMID:
11994370
12.

Starting dose of levothyroxine for the treatment of congenital hypothyroidism: a systematic review.

Hrytsiuk I, Gilbert R, Logan S, Pindoria S, Brook CG.

Arch Pediatr Adolesc Med. 2002 May;156(5):485-91. Review.

PMID:
11980555
13.

Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty?

Charmandari E, Brook CG, Hindmarsh PC.

Arch Dis Child. 2002 Apr;86(4):266-9. Review.

14.

Kinetics and effect of percutaneous administration of dihydrotestosterone in children.

Charmandari E, Dattani MT, Perry LA, Hindmarsh PC, Brook CG.

Horm Res. 2001;56(5-6):177-81.

PMID:
11910204
15.

Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?

Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.

J Clin Endocrinol Metab. 2001 Oct;86(10):4679-85.

PMID:
11600525
16.

Molecular and structural analysis of two novel StAR mutations in patients with lipoid congenital adrenal hyperplasia.

Achermann JC, Meeks JJ, Jeffs B, Das U, Clayton PE, Brook CG, Jameson JL.

Mol Genet Metab. 2001 Aug;73(4):354-7.

PMID:
11509019
17.

Congenital adrenal hyperplasia: management during critical illness.

Charmandari E, Lichtarowicz-Krynska EJ, Hindmarsh PC, Johnston A, Aynsley-Green A, Brook CG.

Arch Dis Child. 2001 Jul;85(1):26-8.

18.

2000 Andrea Prader Prize. Summary of Andrea Prader Lecture 2000.

Brook CG.

Horm Res. 2000;54(3):153-4. No abstract available.

19.

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.

Charmandari E, Hindmarsh PC, Johnston A, Brook CG.

J Clin Endocrinol Metab. 2001 Jun;86(6):2701-8.

PMID:
11397874
20.

Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Charmandari E, Johnston A, Brook CG, Hindmarsh PC.

J Endocrinol. 2001 Apr;169(1):65-70.

PMID:
11250647
21.

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

Swerdlow AJ, Reddingius RE, Higgins CD, Spoudeas HA, Phipps K, Qiao Z, Ryder WD, Brada M, Hayward RD, Brook CG, Hindmarsh PC, Shalet SM.

J Clin Endocrinol Metab. 2000 Dec;85(12):4444-9.

PMID:
11134091
22.

Which children should receive growth hormone treatment. Reserve it for the GH deficient.

Brook CG.

Arch Dis Child. 2000 Aug;83(2):176-8. No abstract available.

23.

Side effects of steroids revisited.

Brook CG.

J Pediatr. 2000 Jul;137(1):3-4. No abstract available.

PMID:
10891811
24.

Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.

Brook CG.

Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F176-81. Review. No abstract available.

25.

Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy?

Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG.

Clin Endocrinol (Oxf). 2000 Apr;52(4):519-24. Review. Erratum in: Clin Endocrinol (Oxf) 2000 Jun;52(6):801.

PMID:
10762296
27.

The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome.

Nathwani NC, Unwin R, Brook CG, Hindmarsh PC.

Clin Endocrinol (Oxf). 2000 Mar;52(3):371-7.

PMID:
10718836
28.

Blood pressure and Turner syndrome.

Nathwani NC, Unwin R, Brook CG, Hindmarsh PC.

Clin Endocrinol (Oxf). 2000 Mar;52(3):363-70.

PMID:
10718835
30.

Compliance with growth hormone treatment - is it a problem?

Hindmarsh PC, Brook CG.

Horm Res. 1999;51 Suppl 3:104-8. Review.

PMID:
10592452
31.

Treatment of late puberty.

Brook CG.

Horm Res. 1999;51 Suppl 3:101-3. Review.

PMID:
10592451
32.

Mechanism of puberty.

Brook CG.

Horm Res. 1999;51 Suppl 3:52-4. Review.

PMID:
10592444
33.

Leptin concentrations in maternal serum and cord blood: relationship to maternal anthropometry and fetal growth.

Geary M, Pringle PJ, Persaud M, Wilshin J, Hindmarsh PC, Rodeck CH, Brook CG.

Br J Obstet Gynaecol. 1999 Oct;106(10):1054-60.

PMID:
10519431
34.

Thyrotoxicosis in children: thirty years' experience.

Raza J, Hindmarsh PC, Brook CG.

Acta Paediatr. 1999 Sep;88(9):937-41.

PMID:
10519332
35.

Treatment of achondroplasia with growth hormone: six years of experience.

Ramaswami U, Rumsby G, Spoudeas HA, Hindmarsh PC, Brook CG.

Pediatr Res. 1999 Oct;46(4):435-9.

PMID:
10509364
36.

Aiming for perfection: outcome of fetal and neonatal medicine.

Brook CG.

Lancet. 1999 Sep;354 Suppl 2:SII25-7. Review. No abstract available.

PMID:
10507256
37.

A sexually dimorphic pattern of growth hormone secretion in the elderly.

Hindmarsh PC, Dennison E, Pincus SM, Cooper C, Fall CH, Matthews DR, Pringle PJ, Brook CG.

J Clin Endocrinol Metab. 1999 Aug;84(8):2679-85.

PMID:
10443659
38.

Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children.

Achermann JC, Brook CG, Robinson IC, Matthews DR, Hindmarsh PC.

Clin Endocrinol (Oxf). 1999 Mar;50(3):301-8.

PMID:
10435054
39.

20 years of experience in idiopathic central diabetes insipidus.

Charmandari E, Brook CG.

Lancet. 1999 Jun 26;353(9171):2212-3. No abstract available.

PMID:
10392992
40.

Androgen secreting adrenocortical tumours.

Wolthers OD, Cameron FJ, Scheimberg I, Honour JW, Hindmarsh PC, Savage MO, Stanhope RG, Brook CG.

Arch Dis Child. 1999 Jan;80(1):46-50.

41.

Growth in children with craniopharyngioma following surgery.

Tiulpakov AN, Mazerkina NA, Brook CG, Hindmarsh PC, Peterkova VA, Gorelyshev SK.

Clin Endocrinol (Oxf). 1998 Dec;49(6):733-8.

PMID:
10209560
42.

Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency.

Mitchell H, Dattani MT, Nanduri V, Hindmarsh PC, Preece MA, Brook CG.

Arch Dis Child. 1999 May;80(5):443-7.

43.

The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours.

Achermann JC, Hindmarsh PC, Brook CG.

Clin Endocrinol (Oxf). 1998 Nov;49(5):639-45.

PMID:
10197080
44.

Growth hormone therapy in hypochondroplasia.

Ramaswami U, Hindmarsh PC, Brook CG.

Acta Paediatr Suppl. 1999 Feb;88(428):116-7. Review.

PMID:
10102069
45.

Evidence for an association between birth weight and blood pressure.

Hindmarsh PC, Brook CG.

Acta Paediatr Suppl. 1999 Feb;88(428):66-9. Review.

PMID:
10102055
46.

Tests of adrenal insufficiency.

Agwu JC, Spoudeas H, Hindmarsh PC, Pringle PJ, Brook CG.

Arch Dis Child. 1999 Apr;80(4):330-3.

47.

Skeletal dysplasias.

Brook CG, de Vries BB.

Arch Dis Child. 1998 Sep;79(3):285-9. Review. No abstract available.

48.

Short stature never killed anybody.

Brook CG.

J Pediatr. 1998 Nov;133(5):591-2. No abstract available.

PMID:
9821412
49.

Gonadotrophin pulsatility in girls with the Turner syndrome: modulation by exogenous sex steroids.

Nathwani NC, Hindmarsh PC, Massarano AA, Brook CG.

Clin Endocrinol (Oxf). 1998 Jul;49(1):107-13.

PMID:
9797854
50.

Oestrogen treatment of tall stature.

Brook CG, Stanhope R, Preece MA, Green AA, Hindmarsh PC.

Arch Dis Child. 1998 Aug;79(2):199. No abstract available.

Supplemental Content

Loading ...
Support Center